Suppr超能文献

心脏手术后行左后心包切开术预防心房颤动:一项适应性、单中心、单盲、随机、对照试验。

Posterior left pericardiotomy for the prevention of atrial fibrillation after cardiac surgery: an adaptive, single-centre, single-blind, randomised, controlled trial.

机构信息

Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, NY, USA.

Department of Cardiovascular Medicine, Fondazione Policlinico Universitario A Gemelli IRCCS, Rome, Italy; Department of Cardiovascular and Pulmonary Sciences, Catholic University of the Sacred Heart, Rome, Italy.

出版信息

Lancet. 2021 Dec 4;398(10316):2075-2083. doi: 10.1016/S0140-6736(21)02490-9. Epub 2021 Nov 14.

Abstract

BACKGROUND

Atrial fibrillation is the most common complication after cardiac surgery and is associated with extended in-hospital stay and increased adverse outcomes, including death and stroke. Pericardial effusion is common after cardiac surgery and can trigger atrial fibrillation. We tested the hypothesis that posterior left pericardiotomy, a surgical manoeuvre that drains the pericardial space into the left pleural cavity, might reduce the incidence of atrial fibrillation after cardiac surgery.

METHODS

In this adaptive, randomised, controlled trial, we recruited adult patients (aged ≥18 years) undergoing elective interventions on the coronary arteries, aortic valve, or ascending aorta, or a combination of these, performed by members of the Department of Cardiothoracic Surgery from Weill Cornell Medicine at the New York Presbyterian Hospital in New York, NY, USA. Patients were eligible if they had no history of atrial fibrillation or other arrhythmias or contraindications to the experimental intervention. Eligible patients were randomly assigned (1:1), stratified by CHADS-VASc score and using a mixed-block randomisation approach (block sizes of 4, 6, and 8), to posterior left pericardiotomy or no intervention. Patients and assessors were blinded to treatment assignment. Patients were followed up until 30 days after hospital discharge. The primary outcome was the incidence of atrial fibrillation during postoperative in-hospital stay, which was assessed in the intention-to-treat (ITT) population. Safety was assessed in the as-treated population. This study is registered with ClinicalTrials.gov, NCT02875405, and is now complete.

FINDINGS

Between Sept 18, 2017, and Aug 2, 2021, 3601 patients were screened and 420 were included and randomly assigned to the posterior left pericardiotomy group (n=212) or the no intervention group (n=208; ITT population). The median age was 61·0 years (IQR 53·0-70·0), 102 (24%) patients were female, and 318 (76%) were male, with a median CHADS-VASc score of 2·0 (IQR 1·0-3·0). The two groups were balanced with respect to clinical and surgical characteristics. No patients were lost to follow-up and data completeness was 100%. Three patients in the posterior left pericardiotomy group did not receive the intervention. In the ITT population, the incidence of postoperative atrial fibrillation was significantly lower in the posterior left pericardiotomy group than in the no intervention group (37 [17%] of 212 vs 66 [32%] of 208 [p=0·0007]; odds ratio adjusted for the stratification variable 0·44 [95% CI 0·27-0·70; p=0·0005]). Two (1%) of 209 patients in the posterior left pericardiotomy group and one (<1%) of 211 in the no intervention group died within 30 days after hospital discharge. The incidence of postoperative pericardial effusion was lower in the posterior left pericardiotomy group than in the no intervention group (26 [12%] of 209 vs 45 [21%] of 211; relative risk 0·58 [95% CI 0·37-0·91]). Postoperative major adverse events occurred in six (3%) patients in the posterior left pericardiotomy group and in four (2%) in the no intervention group. No posterior left pericardiotomy related complications were seen.

INTERPRETATION

Posterior left pericardiotomy is highly effective in reducing the incidence of atrial fibrillation after surgery on the coronary arteries, aortic valve, or ascending aorta, or a combination of these without additional risk of postoperative complications.

FUNDING

None.

摘要

背景

心房颤动是心脏手术后最常见的并发症,与住院时间延长和不良后果增加有关,包括死亡和中风。心脏手术后心包积液很常见,可引发心房颤动。我们假设左后心包切开术(一种将心包腔引流到左胸膜腔的手术操作)可能会降低心脏手术后心房颤动的发生率。

方法

在这项适应性、随机、对照试验中,我们招募了在纽约长老会医院威尔康奈尔医学中心心胸外科进行冠状动脉、主动脉瓣或升主动脉手术或这些手术联合手术的成年患者(年龄≥18 岁)。如果患者没有心房颤动或其他心律失常病史,或没有实验干预的禁忌症,则符合入组条件。符合条件的患者被随机分配(1:1),根据 CHADS-VASc 评分和使用混合块随机分组方法(块大小为 4、6 和 8)分为左后心包切开术组或无干预组。患者和评估者对治疗分配均不知情。患者随访至出院后 30 天。主要结局是术后住院期间心房颤动的发生率,在意向治疗(ITT)人群中进行评估。安全性在实际治疗人群中进行评估。本研究在 ClinicalTrials.gov 注册,NCT02875405,现已完成。

结果

2017 年 9 月 18 日至 2021 年 8 月 2 日,筛查了 3601 名患者,纳入了 420 名患者并随机分配到左后心包切开术组(n=212)或无干预组(n=208;ITT 人群)。中位年龄为 61.0 岁(IQR 53.0-70.0),102 名(24%)患者为女性,318 名(76%)为男性,中位 CHADS-VASc 评分为 2.0(IQR 1.0-3.0)。两组在临床和手术特征方面平衡。无患者失访,数据完整性为 100%。左后心包切开术组有 3 名患者未接受干预。在 ITT 人群中,左后心包切开术组术后心房颤动的发生率明显低于无干预组(212 例中的 37 例[17%] vs 208 例中的 66 例[32%];p=0.0007;经分层变量调整的比值比 0.44[95%CI 0.27-0.70;p=0.0005])。左后心包切开术组 209 例患者中有 2 例(1%)和无干预组 211 例患者中有 1 例(<1%)在出院后 30 天内死亡。左后心包切开术组术后心包积液的发生率低于无干预组(209 例中的 26 例[12%] vs 211 例中的 45 例[21%];相对风险 0.58[95%CI 0.37-0.91])。左后心包切开术组有 6 例(3%)患者和无干预组有 4 例(2%)患者发生术后主要不良事件。未观察到与左后心包切开术相关的并发症。

结论

左后心包切开术可有效降低冠状动脉、主动脉瓣或升主动脉手术或这些手术联合手术后心房颤动的发生率,且不会增加术后并发症的风险。

该译文是基于原文进行的翻译,由于原文内容可能存在表述不清晰的地方,因此,译文也可能存在理解上的偏差,具体内容请以原文为准。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验